Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 272 participants.

Also called NCT07552194

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 272 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07552194
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07552194. Randomized; double masking; primary purpose treatment. Start 2026-06-02 (anticipated); primary completion 2027-12-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)
Acronym
ROBUST
Condition
Coronary Bifurcation Lesion
Condition
Coronary Stenting
Condition
Drug Eluting Balloon
Intervention (Device)
Balloon Angioplasty with or without drug administration
Lead sponsor
Avtandil M. Babunashvili (class: other)
Collaborator
I.M. Sechenov First Moscow State Medical University (class: other)

Record details

Record id
cardio:ct-nct07552194
Content hash
cf0795b8fdf99dcf83e9af01db2aab69be41b34127a08241e25597694de1c8be